(-)-demecolcine increases expression ISO RGD:1345096 6480464 Demecolcine results in increased expression of PSME4 mRNA CTD PMID:23649840 1,2-dimethylhydrazine decreases expression ISO RGD:1557625 6480464 1, 2-Dimethylhydrazine results in decreased expression of PSME4 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1557625 6480464 Dinitrochlorobenzene results in increased expression of PSME4 mRNA CTD PMID:21404309 1-nitropyrene increases expression ISO RGD:1345096 6480464 1-nitropyrene results in increased expression of PSME4 mRNA CTD PMID:19041380 17beta-estradiol increases expression ISO RGD:1345096 6480464 Estradiol results in increased expression of PSME4 mRNA CTD PMID:16514628 , PMID:23019147 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1345096 6480464 Dihydrotestosterone results in increased expression of PSME4 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1557625 6480464 Tetrachlorodibenzodioxin results in increased expression of PSME4 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1557625 6480464 Tetrachlorodibenzodioxin affects the expression of PSME4 mRNA CTD PMID:21570461 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of PSME4 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:1345096 6480464 beta-methylcholine affects the expression of PSME4 mRNA CTD PMID:21179406 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1557625 6480464 3 more ... CTD PMID:19467301 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1557625 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of PSME4 mRNA CTD PMID:20188158 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of PSME4 mRNA CTD PMID:19162173 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1557625 6480464 Oxazolone results in increased expression of PSME4 mRNA CTD PMID:21404309 afimoxifene decreases expression ISO RGD:1345096 6480464 afimoxifene results in decreased expression of PSME4 mRNA CTD PMID:16514628 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PSME4 mRNA CTD PMID:16483693 arsenous acid increases expression ISO RGD:1345096 6480464 Arsenic Trioxide results in increased expression of PSME4 mRNA CTD PMID:22521957 , PMID:26705709 beauvericin multiple interactions ISO RGD:1345096 6480464 [beauvericin co-treated with enniatins] results in decreased expression of PSME4 protein CTD PMID:32407736 benzene increases expression ISO RGD:1345096 6480464 Benzene results in increased expression of PSME4 mRNA CTD PMID:19162166 benzo[a]pyrene increases expression ISO RGD:1557625 6480464 Benzoapyrene results in increased expression of PSME4 mRNA CTD PMID:21715664 , PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1557625 6480464 Benzoapyrene results in decreased expression of PSME4 protein CTD PMID:23892563 benzo[a]pyrene decreases expression ISO RGD:1345096 6480464 Benzoapyrene results in decreased expression of PSME4 protein CTD PMID:23892563 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PSME4 mRNA CTD PMID:25181051 cisplatin decreases expression ISO RGD:1345096 6480464 Cisplatin results in decreased expression of PSME4 mRNA CTD PMID:27594783 cocaine increases expression ISO RGD:1345096 6480464 Cocaine results in increased expression of PSME4 mRNA CTD PMID:15009677 copper(II) sulfate increases expression ISO RGD:1345096 6480464 Copper Sulfate results in increased expression of PSME4 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:1557625 6480464 Asbestos, Crocidolite results in decreased expression of PSME4 mRNA CTD PMID:29279043 cyclosporin A increases expression ISO RGD:1345096 6480464 Cyclosporine results in increased expression of PSME4 mRNA CTD PMID:20106945 , PMID:25562108 diarsenic trioxide increases expression ISO RGD:1345096 6480464 Arsenic Trioxide results in increased expression of PSME4 mRNA CTD PMID:22521957 , PMID:26705709 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PSME4 mRNA CTD PMID:21266533 dioxygen multiple interactions ISO RGD:1557625 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of PSME4 mRNA] CTD PMID:22629407 dioxygen increases expression ISO RGD:1557625 6480464 Oxygen deficiency results in increased expression of PSME4 mRNA CTD PMID:22629407 dorsomorphin multiple interactions ISO RGD:1345096 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 elesclomol multiple interactions ISO RGD:1345096 6480464 Acetylcysteine inhibits the reaction [elesclomol results in increased expression of PSME4 mRNA] CTD PMID:18723479 elesclomol increases expression ISO RGD:1345096 6480464 elesclomol results in increased expression of PSME4 mRNA CTD PMID:18723479 enniatin multiple interactions ISO RGD:1345096 6480464 [beauvericin co-treated with enniatins] results in decreased expression of PSME4 protein CTD PMID:32407736 ethyl methanesulfonate increases expression ISO RGD:1345096 6480464 Ethyl Methanesulfonate results in increased expression of PSME4 mRNA CTD PMID:23649840 finasteride increases expression EXP 6480464 Finasteride results in increased expression of PSME4 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of PSME4 mRNA CTD PMID:24136188 formaldehyde increases expression ISO RGD:1345096 6480464 Formaldehyde results in increased expression of PSME4 mRNA CTD PMID:20655997 fulvestrant decreases expression ISO RGD:1345096 6480464 fulvestrant results in decreased expression of PSME4 mRNA CTD PMID:16514628 geldanamycin increases expression ISO RGD:1345096 6480464 geldanamycin results in increased expression of PSME4 mRNA CTD PMID:26705709 lead(0) affects expression ISO RGD:1345096 6480464 Lead affects the expression of PSME4 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1345096 6480464 Lead affects the expression of PSME4 mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO RGD:1345096 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of PSME4 mRNA CTD PMID:26667767 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of PSME4 mRNA CTD PMID:30467583 methyl methanesulfonate increases expression ISO RGD:1345096 6480464 Methyl Methanesulfonate results in increased expression of PSME4 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1345096 6480464 methylmercuric chloride results in increased expression of PSME4 mRNA CTD PMID:23179753 more ... miconazole decreases expression ISO RGD:1557625 6480464 Miconazole results in decreased expression of PSME4 mRNA CTD PMID:27462272 N-acetyl-L-cysteine multiple interactions ISO RGD:1345096 6480464 Acetylcysteine inhibits the reaction [elesclomol results in increased expression of PSME4 mRNA] CTD PMID:18723479 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of PSME4 mRNA CTD PMID:24136188 nickel dichloride decreases expression ISO RGD:1345096 6480464 nickel chloride results in decreased expression of PSME4 mRNA CTD PMID:17312168 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of PSME4 mRNA CTD PMID:24136188 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PSME4 mRNA CTD PMID:25729387 p-chloromercuribenzoic acid multiple interactions ISO RGD:1345096 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PSME4 mRNA CTD PMID:27188386 phenobarbital affects expression ISO RGD:1557625 6480464 Phenobarbital affects the expression of PSME4 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1345096 6480464 Phenylmercuric Acetate results in increased expression of PSME4 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1345096 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PSME4 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:1557625 6480464 pirinixic acid results in increased expression of PSME4 mRNA CTD PMID:23811191 quercetin decreases expression ISO RGD:1345096 6480464 Quercetin results in decreased expression of PSME4 mRNA CTD PMID:21632981 raloxifene decreases expression ISO RGD:1345096 6480464 Raloxifene Hydrochloride results in decreased expression of PSME4 mRNA CTD PMID:16514628 resveratrol multiple interactions ISO RGD:1345096 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of PSME4 mRNA CTD PMID:26667767 SB 431542 multiple interactions ISO RGD:1345096 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1345096 6480464 Silicon Dioxide results in increased expression of PSME4 mRNA CTD PMID:25351596 silver atom increases expression ISO RGD:1345096 6480464 Silver results in increased expression of PSME4 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1345096 6480464 Silver results in increased expression of PSME4 mRNA CTD PMID:26014281 sodium arsenate increases expression ISO RGD:1557625 6480464 sodium arsenate results in increased expression of PSME4 mRNA CTD PMID:21795629 testosterone enanthate affects expression ISO RGD:1345096 6480464 testosterone enanthate affects the expression of PSME4 mRNA CTD PMID:17440010 thimerosal decreases expression ISO RGD:1345096 6480464 Thimerosal results in decreased expression of PSME4 mRNA CTD PMID:27188386 toluene 2,4-diisocyanate increases expression ISO RGD:1557625 6480464 Toluene 2, 4-Diisocyanate results in increased expression of PSME4 mRNA CTD PMID:21404309 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PSME4 mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PSME4 mRNA CTD PMID:19448997 trichostatin A increases expression ISO RGD:1345096 6480464 trichostatin A results in increased expression of PSME4 mRNA CTD PMID:24935251 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1345096 6480464 tris2-butoxyethyl phosphate affects the expression of PSME4 mRNA CTD PMID:29024780 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of PSME4 mRNA CTD PMID:24136188 valproic acid increases expression ISO RGD:1345096 6480464 Valproic Acid results in increased expression of PSME4 mRNA CTD PMID:29154799 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of PSME4 mRNA CTD PMID:29427782 valproic acid decreases expression ISO RGD:1345096 6480464 Valproic Acid results in decreased expression of PSME4 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of PSME4 mRNA CTD PMID:21318169 vincaleukoblastine affects response to substance ISO RGD:1345096 6480464 PSME4 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of PSME4 mRNA CTD PMID:23034163 vincristine increases expression ISO RGD:1345096 6480464 Vincristine results in increased expression of PSME4 mRNA CTD PMID:23649840 vorinostat decreases expression ISO RGD:1345096 6480464 vorinostat results in decreased expression of PSME4 mRNA CTD PMID:27188386
